To Market, To Market-2003

Annual Reports in Medicinal Chemistry

Volumn 39, Issue , 2004, Pages 335-368

  Hegde, Shridhar ^a   Carter, Jeffery ^a  

^a PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33644509882     PISSN: 00657743     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0065-7743(04)39025-1     Document Type: Review

References (104)

1. The collection of new therapeutic entities first launched in 2003 originated from the following sources: (a) CIPSLINE, Prous database; (b) Iddb, Current Drugs database; (c) IMS R&D Focus; (d) Adis Business Intelligence R&D Insight; (e) Pharmaprojects.
2. Graul A.I. Drug News Perspect 17 (2004) 43
3. Boyer-Joubert C., Lorthiois E., and Moreau F. Ann. Rep. Med. Chem 38 (2003) 347
4. Bernardelli P., Gaudilliere B., and Vergne F. Ann. Rep. Med. Chem 37 (2002) 257
5. Gaudilliere B., Bernardelli P., and Berna P. Ann. Rep. Med. Chem 36 (2001) 293
6. Emery P. Drugs Today 39 Suppl. B (2003) 17
7. Edwards L.A. Formulary 38 (2003) 272
8. Weisman M.H., Moreland L.W., Furst D.E., Weinblatt M.E., Keystone E.C., Paulus H.E., Teoh L.S., Velagapudi R.B., Noertersheuser P.A., Granneman G.R., Fischkoff S.A., and Chartash E.K. Clin. Ther 25 (2003) 1700
9. Machold K.P., and Smolen J.S. Exp. Opin. Biol. Ther 3 (2003) 351
10. Weinblatt M.E., Keystone E.C., Furst D.E., Moreland L.W., Weisman M.H., Birbara C.A., Teoh L.A., Fischkoff S.A., and Chartash E.K. Arthritis Rheum 48 (2003) 3
11. Bashir S.J., and Maibach H.I. Curr. Opin. Invest. Drugs 2 (2001) 631
12. Ormerod A.D. Curr. Opin. Invest. Drugs 4 (2003) 608
13. Vaishnaw A.K., and TenHoor C.N. J. Pharmacokinet. Pharmacodyn 29 (2003) 415
14. Sorbera L.A., Revel L., and Fernandez R. Drugs Future 26 (2001) 527
15. Kaplon R.J., Hochman P.S., Michler R.E., Kwiatkowski P.A., Edwards N.M., Berger C.L., Xu H., Meier W., Wallner B.P., Chisholm P., and Marboe C.C. Transplantation 61 (1996) 356
16. Hale J.J., Mills S.G., MacGoss M., Finke P.E., Cascieri M.A., Sadowski S., Ber E., Chicchi G.G., Kurtz M., Metzger J., Eiermann G., et al. J. Med. Chem 41 (1998) 4607
17. Sorbera L.A., Castaňer J., Bayes M., and Silvestre J. Drugs Future 27 (2002) 211
18. Chawla S.P., Gralla R.J., Hesketh P.J., Grunberg S.M., Elmer M.E., and Horgan K.J. Proc. Am. Soc. Clin. Oncol 19 (2001) 1759
19. Chawla S.P., Grunberg S.M., Gralla R.J., Hesketh P.J., Rittenberg C., Elmer M.E., Schmidt C., Taylor A., Carides A.D., Evans J.K., and Horgan K.J. Cancer 97 (2003) 2290
20. Goldsmith D.R., and Perry C.M. Drugs 63 (2003) 1679
21. Bold G., Fassler A., Capraro H.G., Cozens R., Klimkait T., Lazdins J., Mestan J., Poncioni B., Rosel J., Stover D., Tintelnot Blomley M., et al. J. Med. Chem 41 (1998) 3387
22. Piliero P.J. Exp. Opin. Invest. Drugs 11 (2002) 1295
23. Rabasseda X., Silvestre J., and Castaňer J. Drugs Future 24 (1999) 375
24. Robinson B.S., Riccardi K.A., Gong Y.F., Guo Q., Stock D.A., Blair W.S., Terry B.J., Deminie C.A., Djang F., Colonno R.J., and Lin P.F. Antimicrob. Agents Chemother 44 (2000) 2093
25. Bracher F., and Litz T. Bioorg. Med. Chem 4 (1996) 877-880
26. Wong D.T., Threlkeld P.G., Best K.L., and Bymaster F.P. J. Pharm. Exp. Ther 222 (1982) 61
27. Spealman R.D. J. Pharm. Exp. Ther 275 (1995) 53
28. Baldinger S.L., and Yogman M.W. Formulary 38 (2003) 85
29. Wellington K., and Scott L.J. Drugs 63 (2003) 2613
30. Kobayashi T., Inoue T., Nishino S., Fujihara Y., Oizumi K., and Kimura T. Chem. Pharm. Bull 43 (1995) 797
31. H. Koike, M. Yoshimoto and H. Nishino, EP 266922 A1 & B1, 1988.
32. Adams J., Behnke M., Chen S., Cruickshank A.A., Dick L.R., Grenier L., Klunder J.M., Ma Y.T., Plamondon L., and Stein R.L. Bioorg. Med. Chem. Lett 8 (1998) 333
33. Lightcap E.S., McCormack T.A., Pien C.S., Chau V., Adams J., and Elliott P.J. Clin. Chem 46 (2000) 673
34. Adams J. Semin. Oncol 28 (2001) 613
35. Hideshima T., Richardson P., Chauhan D., Palombella V.J., Elliott P.J., Adams J., and Anderson K.C. Cancer Res 61 (2001) 3071
36. Elliott P.J., and Ross J.S. Am. J. Clin. Pathol 116 (2001) 637
37. Kisselev A.F., and Goldberg A.L. Chem. Biol 8 (2001) 739
38. Kies M.S., and Harari P.M. Curr. Opin. Invest. Drugs 3 (2002) 1385
39. Etessami A., and Bourhis J. Drugs Future 25 (2000) 895
40. Reynolds N.A., and Wagstaff A.J. Drugs 64 (2004) 109
41. Sun H.K., Kuti J.L., and Nicolau D.P. Formulary 38 (2003) 634
42. Raja A., LaBonte J., Lebbos J., and Kirkpatrick P. Nat. Rev. Drug Discov 2 (2003) 942
43. Tally F.P., and DeBruin M.F. J. Antimicrob. Chemother 46 (2000) 523
44. Rybak M.J., Hershberger E., Moldovan T., and Grucz R.G. Antimicrob. Agents Chemother 44 (2000) 1062
45. Dedrick R.L., Walicke P., and Garovoy M. Transpl. Immunol 9 (2002) 181
46. Gottlieb A., Krueger J.G., Bright R., Ling M., Lebwohl M., Kang S., Feldman S., Spellman M., Wittkowski K., Ochs A.J., Jardieu P., et al. J. Am. Acad. Dermatol 42 (2000) 428
47. Bauer R.J., Dedrick R.L., White M.L., Murray M.J., and Garovoy M.R. J. Pharmacokinet. Biopharm 27 (1999) 397
48. Rybak M., Hershberger E., Moldovan T., and Grucz R.G. Antimicrob. Agents Chemother 44 (2000) 1062
49. Bang L.M., and Scott L.J. Drugs 63 (2003) 2413
50. Jeong L.S., Schinazi R.F., Beach J.W., Kim H.O., Nampalli S., Shanmuganathan K., Alves A.J., McMillan A., Chu C.K., and Mathis R. J. Med. Chem 36 (1993) 181
51. Schinazi R.F., McMillan A., Cannon D., Mathis R., Lloyd R.M., Peck A., Sommadossi J.P., St Clair M., Wilson J., Furman P.A., Painter G., and Choi W.B. Antimicrob. Agents Chemother 36 (1992) 2423
52. G. R. Painter, D. C. Liotta, M. Almond, D. Cleary and J. Soria, WO 2000009494 A1, 2000.
53. Jiang S., Lin K., Strick N., and Neurath A.R. Biochem. Biophys. Res. Commun 195 (1993) 533
54. Cammack N. Curr. Opin. Infect. Dis 14 (2001) 13
55. Wild C., Oas T., McDanal C., Bolognesi D., and Matthews T. Proc. Nat. Acad. Sci 89 (1992) 10537
56. Ketas T.J., Frank I., Klasse P.J., Sullivan B.M., Gardner J.P., Splenlehauer C., Nesin M., Olson W.C., Moore J.P., and Pope M. J. Virol 77 (2003) 2762
57. Nagashima K.A., Thompson D.A., Rosenfield S.I., Maddon P.J., Dragic T., and Olson W.C. J. Infect. Dis 183 (2001) 1121
58. Martin J., and Krum H. Curr. Opin. Invest. Drugs 2 (2001) 521
59. McMahon E.G. Curr. Opin. Pharmacol 1 (2001) 190
60. Rabasseda X., Silvestre J., and Castaňer J. Drugs Future 24 (1999) 488
61. Sorbera L.A., Martin L., Castaňer J., and Castaňer R.M. Drugs Future 26 (2001) 224
62. Corbett A.H., and Kashuba A.D.M. Curr. Opin. Invest. Drugs 3 (2002) 384
63. Belshe R., Mendelman P., Treanor J., King J., Gruber W., Piedra P., Bernstein D., Hayden F.G., Kotloff K., Zangwill K., Iacuzio D., and Wolff M. N. Engl. J. Med 338 (1998) 1405
64. Nichol K.L., Mendelman P.M., Mallon K.P., Jackson L.A., Gorse G.J., Belshe R.B., Glezen W.P., and Wittes J. JAMA 282 (1999) 137
65. Treanor J.J., Kotloff K., Betts R.F., Belshe R., Newman F., Iacuzio D., Wittes J., and Bryant M. Vaccine 18 (2000) 899
66. McIntyre J.A. Drugs Future 28 (2003) 432
67. Kakkis E.D., Muenzer J., Tiller G.E., Waber L., Belmont J., Passage M., Izikowski B., Phillips J., Doroshow R., Walot I., Hoft R., and Neufeld E. N. Engl. J. Med 344 (2001) 182
68. Sorbera L.A., Castaňer J., and Bayes M. Drugs Future 28 (2003) 229
69. Lachmann R.H. Curr. Opin. Invest. Drugs 4 (2003) 472
70. Pastores G.M., and Barnett N.L. Expert Opin. Invest. Drugs 12 (2003) 273
71. Gabardi S., Tran J.L., and Clarkson M.R. Ann. Pharmacother 37 (2003) 1685
72. Graul A.I., and Collins A.M. Drugs Future 28 (2003) 273
73. Cullell-Young M., Bayes M., and Leeson P.A. Drugs Future 27 (2001) 537
74. Busse W., Corren J., Lanier B.Q., McAlary M., Fowler-Taylor A., Cioppa G.D., van As A., and Gupta N. J. Allergy Clin. Immunol 108 (2001) 184
75. Corren J., Casale T., Deniz Y., and Ashby M. J. Allergy Clin. Immunol 111 (2003) 87
76. Stacher G. Curr. Opin. Invest. Drugs 3 (2002) 1502
77. DiVall M.V., and Cersosimo R.J. Formulary 38 (2003) 414
78. Kowalczyk B.A., and Dvorak C.A. Synthesis 7 (1996) 816
79. Graul A., and Castaňer J. Drugs Future 21 (1996) 906
80. Stewart P.M. Eur. J. Endocrinol 148 (2003) S27
81. Trainer P.J., Drake W.M., Katznelson L., Freda P.U., Herman-Bonert V., van der Lely A.J., Dimaraki E.V., Stewart P.M., Friend K.E., Vance M.L., Besser G.M., and Scarlett J.A. N. Engl. J. Med 344 (2001) 182
82. Rabasseda X., and Leeson P. Drugs Future 24 (1999) 969
83. Iglesias P., and Diez J.J. Expert Opin. Invest. Drugs 12 (2003) 1777
84. Kajinami K., Mabuchi H., and Saito Y. Expert Opin. Invest. Drugs 9 (2000) 2653
85. Flores N.A. Curr. Opin. Invest. Drugs 3 (2002) 1334
86. Isley W.L. Drugs Today 37 (2001) 587
87. Graul A., and Castaňer J. Drugs Future 24 (1999) 511
88. Information Update, Drugs Future 2003, 28, 617.
89. White C.M. J. Clin. Pharmacol 42 (2002) 963
90. Davidson M.H. Expert Opin. Invest. Drugs 11 (2002) 125
91. Izquierdo I., Merlos M., and Garcia-Rafanell J. Drugs Today 39 (2003) 451
92. Garcia-Rafanell J., Uriach J., and Cia. Drugs Future 21 (1996) 1032
93. Carceller E., Merlos M., Giral M., Balsa D., Almansa C., Bartroli J., Garcia-Rafanell J., and Forn J. J. Med. Chem 37 (1994) 2697
94. Sorbera L.A., Martin L., Leeson P.A., and Castaňer J. Drugs Future 26 (2001) 15
95. Rotella D.P. Curr. Opin. Invest. Drugs 4 (2003) 60
96. Kuan J., and Brock G. Expert Opin. Invest. Drugs 11 (2002) 1605
97. Uckert S., Stief C.G., and Jonas U. Expert Opin. Invest. Drugs 12 (2003) 1521
98. Rosen R.C., and Costis J.B. Am. J. Cardiol 92 (2003) 9
99. Cheson B. Curr. Opin. Invest. Drugs 3 (2002) 165
100. Culy C.R., and Lamb H.M. BioDrugs 14 (2000) 195
101. Coleman C.I., Carabino J.M., Vergara C.M., and Wang F. Formulary 38 (2003) 131
102. Young J.M. Expert Opin. Invest. Drugs 11 (2002) 1487
103. Sommer F., and Engelmann U. Curr. Opin. Invest. Drugs 3 (2002) 607
104. Sorbera L.A., Martin L., Rabasseda X., and Castaňer J. Drugs Future 26 (2001) 141